Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Levy

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|December 21, 2024
Primary biliary cholangitis: Personalizing second-line therapiesCynthia Levy, Christopher L Bowlus
Journal of Hepatology|February 20, 2003
Current management of primary biliary cirrhosis and primary sclerosing cholangitisCynthia Levy, Keith D Lindor
Clinics in Liver Disease|October 21, 2022
Novel Therapies in Primary Biliary Cholangitis: What Is in the Pipeline?Keri-Ann Buchanan-Peart, Cynthia Levy
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2023
New Treatment Paradigms in Primary Biliary CholangitisCynthia Levy, Michael Manns, Gideon Hirschfield
Clinics in Liver Disease|April 2, 2013
Primary biliary cirrhosis: therapeutic advancesFrank Czul, Adam Peyton, Cynthia Levy
Clinical Liver Disease|February 2, 2024
Autoimmune hepatitis and pregnancyNathalie A Pena Polanco, Cynthia Levy
Gastroenterology|August 4, 2009
An uncommon cause of iron deficiency anemiaEmmanuelle D Williams, Alex Seamon, Cynthia Levy
Clinical and Translational Gastroenterology|August 28, 2015
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisSeth N Sclair, Ester Little, Cynthia Levy
Hepatology Communications|June 2, 2023
Primary biliary cholangitis: Epidemiology, prognosis, and treatmentJuan Trivella, Binu V John, Cynthia Levy
The New England Journal of Medicine|May 29, 2024
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. ReplyKris V Kowdley, Cynthia Levy, David Jones
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|December 21, 2024
Primary biliary cholangitis: Personalizing second-line therapiesCynthia Levy, Christopher L Bowlus
Journal of Hepatology|February 20, 2003
Current management of primary biliary cirrhosis and primary sclerosing cholangitisCynthia Levy, Keith D Lindor
Clinics in Liver Disease|October 21, 2022
Novel Therapies in Primary Biliary Cholangitis: What Is in the Pipeline?Keri-Ann Buchanan-Peart, Cynthia Levy
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2023
New Treatment Paradigms in Primary Biliary CholangitisCynthia Levy, Michael Manns, Gideon Hirschfield
Clinics in Liver Disease|April 2, 2013
Primary biliary cirrhosis: therapeutic advancesFrank Czul, Adam Peyton, Cynthia Levy
Clinical Liver Disease|February 2, 2024
Autoimmune hepatitis and pregnancyNathalie A Pena Polanco, Cynthia Levy
Gastroenterology|August 4, 2009
An uncommon cause of iron deficiency anemiaEmmanuelle D Williams, Alex Seamon, Cynthia Levy
Clinical and Translational Gastroenterology|August 28, 2015
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisSeth N Sclair, Ester Little, Cynthia Levy
Hepatology Communications|June 2, 2023
Primary biliary cholangitis: Epidemiology, prognosis, and treatmentJuan Trivella, Binu V John, Cynthia Levy
The New England Journal of Medicine|May 29, 2024
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. ReplyKris V Kowdley, Cynthia Levy, David Jones
Pageof 21